Skip to main content
Clinical Trials/PACTR202203635372753
PACTR202203635372753
Recruiting
Phase 4

Primary EUS-guided biliary drainage Versus ERCP biliary drainage in distal malignant biliary obstruction

Theodr Bilharz Research institute0 sites66 target enrollmentFebruary 13, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Theodr Bilharz Research institute
Enrollment
66
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 13, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Theodr Bilharz Research institute

Eligibility Criteria

Inclusion Criteria

  • Patients older than 18 years and diagnosed with malignant obstruction of the distal bile duct.
  • Type of malignancy:
  • ?Primary pancreatic cancer.
  • ?Ampulla of vater carcinoma.
  • ?Distal cholangiocarcinoma.
  • ?Pancreatic neuroendocrine tumor.
  • ?Metastatic lymph nodes.
  • ?Resectable and unresectable tumors will be included.
  • ?Patients with duodenal tumor invasion will be included.
  • Patients with performance A will be included.

Exclusion Criteria

  • Patients with impaired coagulation profile.
  • Patients with sepsis (according to the severity of sepsis index).
  • Low performance.
  • Life expectancy less than 1 month.

Outcomes

Primary Outcomes

Not specified

Similar Trials